文献速递免疫规划传染病防控与疫情报告

重组新城疫病毒载体双途径单剂疫苗对肉鸡H5N1和强毒新城疫的保护效果

Efficacy of dual administration vaccine of recombinant Newcastle disease virus expressing clade 2.3.4.4b H5 hemagglutinin against H5N1 highly pathogenic avian influenza and viscerotropic Velogenic Newcastle disease virus in broilers.
PubMed 文献 · Vaccine · 2026-02-05

本研究用表达clade 2.3.4.4b H5血凝素的重组新城疫病毒载体疫苗(rK148/22-H5),对1日龄肉鸡经双途径单剂接种,并每10天进行高致病性禽流感病毒(HPAIV)和内脏强毒新城疫病毒(vvNDV)攻毒。接种组NDV母源抗体维持至20日龄后,20 dpv起对vvNDV和HPAIV攻毒保护率分别超过70%和90%,30 dpv攻毒后口咽和泄殖腔未检出排毒。该双途径单剂疫苗是保护幼龄鸡的候选方案。

要点

  • 1日龄肉鸡双途径单剂接种rK148/22-H5后,NDV抗体水平维持至20日龄以上。
  • 20 dpv起对vvNDV攻毒保护率超过70%,对HPAIV攻毒保护率超过90%。
  • 30 dpv HPAIV攻毒后口咽和泄殖腔均未检出病毒排毒。

核心结论

  • rK148/22-H5双途径单剂疫苗可有效保护幼龄肉鸡抵抗HPAIV和vvNDV攻毒。

研究设计与样本

  • 研究对1日龄肉鸡接种表达clade 2.3.4.4b H5血凝素的重组新城疫病毒载体疫苗rK148/22-H5,经双途径单剂给药。
  • 接种鸡随机分组,每10天分别进行HPAIV和vvNDV攻毒。

主要发现

  • 对照组NDV母源抗体在20日龄消退,接种组抗体水平维持。
  • 抗HPAIV抗体在接种后20天(20 dpv)首次检出。
  • 20 dpv起对vvNDV攻毒保护率超过70%,对HPAIV攻毒保护率超过90%。
  • 30 dpv HPAIV攻毒后口咽和泄殖腔组织未检出病毒排毒。

临床怎么用

  • 该疫苗候选可用于幼龄肉鸡单剂双途径接种,同时预防HPAIV和vvNDV。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The widespread and endemic nature of recent highly pathogenic avian influenza virus H5N1 clade 2.3.4.4b outbreaks has driven increased vaccine demand. In this study, we used a Newcastle disease virus (NDV) vector expressing clade 2.3.4.4b H5 hemagglutinin (rK148/22-H5) to evaluate the efficacy of a single-dose vaccine administered via dual routes. We vaccinated 1-day-old broilers and randomly assigned them to HPAIV and viscerotropic velogenic NDV (vvNDV) challenges every 10 days. In the control group, maternal NDV antibodies waned by 20 days of age, whereas the antibody levels were sustained in the vaccinated group. Antibodies against HPAIV were first detected at 20 days post vaccination (dpv). Starting at 20 dpv, protection rates exceeded 70% and 90% against vvNDV and HPAIV challenges, respectively. Notably, at 30 dpv, no virus shedding was detected in the oropharyngeal and cloacal tissues following highly pathogenic avian influenza challenge. The rK148/22-H5 vaccine administered via the dual route is a promising candidate for single-dose vaccination to effectively protect young chicks against HPAIV and vvNDV.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Kim DH, Kim JC, Lee SH, et al. Efficacy of dual administration vaccine of recombinant Newcastle disease virus expressing clade 2.3.4.4b H5 hemagglutinin against H5N1 highly pathogenic avian influenza and viscerotropic Velogenic Newcastle disease virus in broilers. Vaccine. 2026. PMID: 41650671. doi:10.1016/j.vaccine.2026.128288

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。